跳至主要内容
临床试验/CTRI/2024/01/061324
CTRI/2024/01/061324尚未招募2 期

Open Randomized Controlled Clinical Trial OF V-Guard (Spatika) Vaginal Pessary In Shwetpradara With Special Reference To Candidiasis Albicans

Dr Dhanashree Raju Ade1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2024年1月13日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
74
试验地点
1
主要终点
To Evaluate The Efficacy Of V Guard Vaginal Pessary Spatika In Shwetpradara

研究概览

简要总结

The Poor Hygiene Of Female Genital Organ Causes Shwetpradara And It is one of the Common Gynaecological Complaint in Gynac OPD

Current Study is Randomized Controlled Clinical Trial To Check The Effectiveness  Of V Guard (Spatika) Vaginal Pessary In The Management Of Shwetpradara

Study Consists Of Two Groups A And B

Drugs

Group A V Guard (Spatika)Vaginal Pessary 200mg Once a Day At Bed Time Placed In Vagina For 7 Days

Group B Clotrimazole Vaginal Pessary 100mg Once a Day At Bed Time Placed In Vagina For 7 Days

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1 All married cases between the age of 20-upto the age of menopause complaining of Shwetapradara 2 Patient confimed by KOH test 3 Cases irrespective of Socio economical status, religion, occupation is included 4 Candidiasis albicans with DM 5 Candidiasis albicans with cervical erotion.

排除标准

  • 1 Unmarried Female patients 2 Per vaginal white discharge other than candidiasis albicans cervical or uterine malignancy pregnant women 3 Cervical polyp.

结局指标

主要结局

To Evaluate The Efficacy Of V Guard Vaginal Pessary Spatika In Shwetpradara

时间窗: 4 Weeks

次要结局

  • To Review The Symptoms Of Shwetpradara From Ayurvedic Literature(To Review The Candidiasis Albicans According To Modern)

研究者

发起方
Dr Dhanashree Raju Ade
申办方类型
Other [[self]]

研究点 (1)

Loading locations...

相似试验